Large Extracellular Loop of Tetraspanin as a Potential Vaccine Candidate for Filariasis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Dakshinamoorthy, Gajalakshmi ^a   Munirathinam, Gnanasekar ^a   Stoicescu, Kristen ^a   Reddy, Maryada Venkatarami ^b   Kalyanasundaram, Ramaswamy ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; TETRASPANIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ARTICLE; BRUGIA MALAYI; BRUGIAN FILARIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LARVA; MALE; MOUSE; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PROTECTION; PROTEIN EXPRESSION; SPLEEN CELL; VACCINATION; WUCHERERIA BANCROFTI;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, HELMINTH; ANTIBODY SPECIFICITY; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, HELMINTH; BRUGIA MALAYI; CROSS REACTIONS; CYTOKINES; FILARIASIS; GENE EXPRESSION; HELMINTH PROTEINS; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; TETRASPANINS; VACCINES;

EID: 84885416758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077394     Document Type: Article

References (56)

1. Michael E, Nutman TB, (2000) Lymphatic filariasis. Tropical Medicine: Science and Practice London: Imperial College Press vol. 1: 41-82.
2. Lahariya C, Tomar SS, (2011) How endemic countries can accelerate lymphatic filariasis elimination? an analytical review to identify strategic and programmatic interventions. J Vector Borne Dis 48: 1-6. PubMed: 21406730.
3. Patel V, Ramasundarahettige C, Vijayakumar L, Thakur JS, Gajalakshmi V, et al. (2012) Suicide mortality in india: A nationally representative survey. Lancet 379: 2343-2351. doi:10.1016/S0140-6736(12)60606-0. PubMed: 22726517.
4. Hotez PJ, (2009) Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin Pharmacol Ther 85: 659-664. doi:10.1038/clpt.2009.16. PubMed: 19322166; Retrieved onpublished at whilst December year 1111 from. doi:10.1038/clpt.2009.16.
5. Madhumathi J, Prince PR, Anugraha G, Kiran P, Rao DN, et al. (2010) Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis. Vaccine 28: 5038-5048. doi:10.1016/j.vaccine.2010.05.012. PubMed: 20653106.
6. Murray J, Gregory WF, Gomez-Escobar N, Atmadja AK, Maizels RM, (2001) Expression and immune recognition of Brugia malayi VAL-1, a homologue of vespid venom allergens and Ancylostoma secreted proteins. Mol Biochem Parasitol 118: 89-96. doi:10.1016/S0166-6851(01)00374-7. PubMed: 11704277.
7. Pokharel DR, Rai R, Nandakumar K, Reddy MV, Rathaur S, (2006) Vaccination with Setaria cervi 175 kDa collagenase induces high level of protection against Brugia malayi infection in jirds. Vaccine 24: 6208-6215. doi:10.1016/j.vaccine.2006.05.103. PubMed: 16870314.
8. Sahoo MK, Sisodia BS, Dixit S, Joseph SK, Gaur RL, et al. (2009) Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection. Vaccine 27: 4263-4271. doi:10.1016/j.vaccine.2009.05.015. PubMed: 19450648.
9. Vedi S, Dangi A, Hajela K, Misra-Bhattacharya S, (2008) Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and Mastomys models. Vaccine 26: 5997-6005. doi:10.1016/j.vaccine.2008.08.073. PubMed: 18817835.
10. Schmid-Hempel P, (2009) Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence. Philos Trans R Soc Lond B Biol Sci 364: 85-98. doi:10.1098/rstb.2008.0157. PubMed: 18930879; Retrieved onpublished at whilst December year 1111 from. doi:10.1098/rstb.2008.0157.
11. Maecker HT, Todd SC, Levy S, (1997) The tetraspanin superfamily: Molecular facilitators. FASEB J 11: 428-442. PubMed: 9194523.
12. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 12: 835-840. doi:10.1038/nm1430. PubMed: 16783371.
13. Tran MH, Freitas TC, Cooper L, Gaze S, Gatton ML, et al. (2010) Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLOS Pathog 6: e1000840. doi:10.1371/journal.ppat.1000840. PubMed: 20419145; Retrieved onpublished at whilst December year 1111 from. doi:10.1371/journal.ppat.1000840.
14. Moribe H, Yochem J, Yamada H, Tabuse Y, Fujimoto T, et al. (2004) Tetraspanin protein (TSP-15) is required for epidermal integrity in Caenorhabditis elegans. J Cell Sci 117: 5209-5220. doi:10.1242/jcs.01403. PubMed: 15454573.
15. Hemler ME, (2003) Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19: 397-422. doi:10.1146/annurev.cellbio.19.111301.153609. PubMed: 14570575.
16. Jones MK, Gobert GN, Zhang L, Sunderland P, McManus DP, (2004) The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions. Bioessays 26: 752-765. doi:10.1002/bies.20058. PubMed: 15221857.
17. Jones EL, Demaria MC, Wright MD, (2011) Tetraspanins in cellular immunity. Biochem Soc Trans 39: 506-511. doi:10.1042/BST0390506. PubMed: 21428929; Retrieved onpublished at whilst December year 1111 from. doi:10.1042/BST0390506.
18. Braschi S, Wilson RA, (2006) Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5: 347-356. doi:10.1074/mcp.M500287-MCP200. PubMed: 16269422.
19. Da'dara AA, Skelly PJ, Wang MM, Harn DA, (2001) Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20: 359-369. doi:10.1016/S0264-410X(01)00374-7. PubMed: 11672898.
20. Da'dara AA, Li YS, Xiong T, Zhou J, Williams GM, et al. (2008) DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 26: 3617-3625. doi:10.1016/j.vaccine.2008.04.080. PubMed: 18524429; Retrieved onpublished at whilst December year 1111 from. doi:10.1016/j.vaccine.2008.04.080.
21. Gnanasekar M, Anand SB, Ramaswamy K, (2008) Identification and cloning of a novel tetraspanin (TSP) homologue from Brugia malayi. DNA Seq 19: 151-156. doi:10.1080/10425170701517614. PubMed: 17852334.
22. Cassone A, Rappuoli R, (2010) Universal vaccines: Shifting to one for many. mBio 1([MedlinePgn:]) doi:10.1128/mBio.00042-10. PubMed: 20689748. Retrieved onpublished at whilst December year 1111 from. doi:10.1128/mBio.00042-10; Retrieved onpublished at whilst December year 1111 from. doi:10.1128/mBio.00042-10.
23. Babayan SA, Allen JE, Taylor DW, (2012) Future prospects and challenges of vaccines against filariasis. Parasite Immunol 34: 243-253. doi:10.1111/j.1365-3024.2011.01350.x. PubMed: 22150082; Retrieved onpublished at whilst December year 1111 from. doi:10.1111/j.1365-3024.2011.01350.x.
24. Taylor MJ, Hoerauf A, Bockarie M, (2010) Lymphatic filariasis and onchocerciasis. Lancet 376: 1175-1185. doi:10.1016/S0140-6736(10)60586-7. PubMed: 20739055; Retrieved onpublished at whilst December year 1111 from. doi:10.1016/S0140-6736(10)60586-7.
25. Anand SB, Rajagopal V, Kaliraj P, (2012) Brugia malayi thioredoxin peroxidase as a potential vaccine candidate antigen for lymphatic filariasis. Appl Biochem Biotechnol 167: 1351-1364. doi:10.1007/s12010-012-9643-6. PubMed: 22528648; Retrieved onpublished at whilst December year 1111 from. doi:10.1007/s12010-012-9643-6.
26. Makepeace BL, Jensen SA, Laney SJ, Nfon CK, Njongmeta LM, et al. (2009) Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure. PLoS Negl Trop. Drosophila Inf Serv 3: e544. doi:10.1371/journal.pntd.0000544; Retrieved onpublished at whilst December year 1111 from. doi:10.1371/journal.pntd.0000544.
27. Wang J, Tricoche N, Du L, Hunter M, Zhan B, et al. (2012) The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates. PLOS ONE 7: e37019. doi:10.1371/journal.pone.0037019. PubMed: 22615877; Retrieved onpublished at whilst December year 1111 from. doi:10.1371/journal.pone.0037019.
28. Steel C, Guinea A, Ottesen EA, (1996) Evidence for protective immunity to bancroftian filariasis in the cook islands. J Infect Dis 174: 598-605. doi:10.1093/infdis/174.3.598. PubMed: 8769619.
29. Rao KV, Eswaran M, Ravi V, Gnanasekhar B, Narayanan RB, et al. (2000) The Wuchereria bancrofti orthologue of Brugia malayi SXP1 and the diagnosis of bancroftian filariasis. Mol Biochem Parasitol 107: 71-80. doi:10.1016/S0166-6851(99)00231-5. PubMed: 10717303.
30. Cho-Ngwa F, Liu J, Lustigman S, (2010) The Onchocerca volvulus cysteine proteinase inhibitor, ov-CPI-2, is a target of protective antibody response that increases with age. PLoS Negl Trop. Drosophila Inf Serv 4: e800. doi:10.1371/journal.pntd.0000800; Retrieved onpublished at whilst December year 1111 from. doi:10.1371/journal.pntd.0000800.
31. MacDonald AJ, Turaga PS, Harmon-Brown C, Tierney TJ, Bennett KE, et al. (2002) Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. Infect Immun 70: 2796-2804. doi:10.1128/IAI.70.6.2796-2804.2002. PubMed: 12010965.
32. Kurniawan-Atmadja A, Sartono E, Partono F, Yazdanbakhsh M, Maizels RM, (1998) Antibody responses to filarial infective larvae are not dominated by the IgG4 isotype. Parasite Immunol 20: 9-17. doi:10.1046/j.1365-3024.1998.t01-1-00118.x. PubMed: 9491413.
33. Veerapathran A, Dakshinamoorthy G, Gnanasekar M, Reddy MV, Kalyanasundaram R, (2009) Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis. PLoS Negl Trop. Drosophila Inf Serv 3: e457. doi:10.1371/journal.pntd.0000457.
34. Dakshinamoorthy G, Samykutty AK, Munirathinam G, Shinde GB, Nutman T, et al. (2012) Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis. PLOS ONE 7: e34077. doi:10.1371/journal.pone.0034077. PubMed: 22496777.
35. Dakshinamoorthy G, Samykutty AK, Munirathinam G, Reddy MV, Kalyanasundaram R, (2013) Multivalent fusion protein vaccine for lymphatic filariasis. Vaccine31: 1616-1622. doi:10.1016/j.vaccine.2012.09.055. PubMed: 23036503; Retrieved onpublished at whilst December year 1111 from. doi:10.1016/j.vaccine.2012.09.055.
36. Abraham D, Grieve RB, Holy JM, Christensen BM, (1989) Immunity to larval Brugia malayi in BALB/c mice: Protective immunity and inhibition of larval development. Am J Trop Med Hyg 40: 598-604. PubMed: 2662785.
37. Samykutty A, Dakshinamoorthy G, Kalyanasundaram R, (2010) Multivalent vaccine for lymphatic filariasis. Procedia Vaccinol 3: 12-18. doi:10.1016/j.provac.2010.11.003. PubMed: 21709765.
38. Levy S, Shoham T, (2005) The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 5: 136-148. doi:10.1038/nri1548. PubMed: 15688041.
39. Cupit PM, Steinauer ML, Tonnessen BW, Eric Agola L, Kinuthia JM, et al. (2011) Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene. Int J Parasitol 41: 1249-1252. doi:10.1016/j.ijpara.2011.07.007. PubMed: 21889508.
40. Teillaud J, (2001) Antibody-dependent cellular cytotoxicity (ADCC). In: Anonymous eLS. John Wiley & Sons, Ltd. Retrieved onpublished at whilst December year 1111 from. doi:10.1002/9780470015902.a0000498.pub2.
41. Zeldenryk LM, Gray M, Speare R, Gordon S, Melrose W, (2011) The emerging story of disability associated with lymphatic filariasis: A critical review. PLoS Negl Trop. Drosophila Inf Serv 5: e1366. doi:10.1371/journal.pntd.0001366; Retrieved onpublished at whilst December year 1111 from. doi:10.1371/journal.pntd.0001366.
42. Anand SB, Gnanasekar M, Thangadurai M, Prabhu PR, Kaliraj P, et al. (2007) Immune response studies with Wuchereria bancrofti vespid allergen homologue (WbVAH) in human lymphatic filariasis. Parasitol Res 101: 981-988. doi:10.1007/s00436-007-0571-2. PubMed: 17558521.
43. Perez-Sanchez R, Ramajo-Hernandez A, Ramajo-Martin V, [!(surname)!], (2006) Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms. Proteomics, 6 (Suppl 2) Suppl 1:: 6-15: S226-36 doi:10.1002/pmic.200500420. PubMed: 17031799.
44. Dang Z, Yagi K, Oku Y, Kouguchi H, Kajino K, et al. (2012) A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology. PLoS Negl Trop. Drosophila Inf Serv 6: e1570. doi:10.1371/journal.pntd.0001570; Retrieved onpublished at whilst December year 1111 from. doi:10.1371/journal.pntd.0001570.
45. Hemler ME, (2001) Specific tetraspanin functions. J Cell Biol 155: 1103-1107. doi:10.1083/jcb.200108061. PubMed: 11756464.
46. Dang Z, Yagi K, Oku Y, Kouguchi H, Kajino K, et al. (2009) Evaluation of Echinococcus multilocularis tetraspanins as vaccine candidates against primary alveolar echinococcosis. Vaccine 27: 7339-7345. doi:10.1016/j.vaccine.2009.09.045. PubMed: 19782112; Retrieved onpublished at whilst December year 1111 from. doi:10.1016/j.vaccine.2009.09.045.
47. Freedman DO, Nutman TB, Ottesen EA, (1989) Protective immunity in bancroftian filariasis selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area. J Clin Invest 83: 14-22-22.
48. Ravindran B, Satapathy AK, Sahoo PK, Mohanty MC, (2003) Protective immunity in human lymphatic filariasis: Problems and prospects. Med Microbiol Immunol 192: 41-46. doi:10.1007/s00430-002-0157-7. PubMed: 12592562.
49. Stewart GR, Zhu Y, Parredes W, Tree TI, Guderian R, et al. (1997) The novel cuticular collagen ovcol-1 of Onchocerca volvulus is preferentially recognized by immunoglobulin G3 from putatively immune individuals. Infect Immun 65: 164-170. PubMed: 8975907.
50. Rozsnyay Z, Sármay G, Walker M, Maslanka K, Valasek Z, et al. (1989) Distinctive role of IgG1 and IgG3 isotypes in Fc gammaR-mediated functions. Immunology 66: 491-498. PubMed: 2523858.
51. Kipps TJ, Parham P, Punt J, Herzenberg LA, (1985) Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med 161: 1-17. doi:10.1084/jem.161.1.1. PubMed: 3918141.
52. Pearson MS, Pickering DA, McSorley HJ, Bethony JM, Tribolet L, et al. (2012) Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop. Drosophila Inf Serv 6: e1564. doi:10.1371/journal.pntd.0001564; Retrieved onpublished at whilst December year 1111 from. doi:10.1371/journal.pntd.0001564.
53. Liu XS, Leerberg J, MacDonald K, Leggatt GR, Frazer IH, (2009) IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host. J Immunol 183: 51-58. doi:10.4049/jimmunol.0802047. PubMed: 19535638; Retrieved onpublished at whilst December year 1111 from. doi:10.4049/jimmunol.0802047.
54. Dash Y, Ramesh M, Kalyanasundaram R, Munirathinam G, Shultz LD, et al. (2011) Granuloma formation around filarial larvae triggered by host responses to an excretory/secretory antigen. Infect Immun 79: 838-845. doi:10.1128/IAI.00128-10. PubMed: 21078849; Retrieved onpublished at whilst December year 1111 from. doi:10.1128/IAI.00128-10.
55. Fan S, Fehr HG, Adams D, (1991) Activation of macrophages for ADCC in vitro: Effects of IL-4, TNF, interferons-α/β, interferon-γ, and GM-CSF. Cell Immunol 135: 78-87. doi:10.1016/0008-8749(91)90255-A. PubMed: 1708310.
56. Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S, (2011) Filariasis in Africa--treatment challenges and prospects. Clin Microbiol Infect 17: 977-985. doi:10.1111/j.1469-0691.2011.03586.x. PubMed: 21722251; Retrieved onpublished at whilst December year 1111 from. doi:10.1111/j.1469-0691.2011.03586.x.